As of 2025-05-30, the EV/EBITDA ratio of Sutro Biopharma Inc (STRO) is 0.44. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. STRO's latest enterprise value is -114.38 mil USD. STRO's TTM EBITDA according to its financial statements is -262.31 mil USD. Dividing these 2 quantities gives us the above STRO EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 10.8x - 13.8x | 13.4x |
| Forward P/E multiples | 17.3x - 29.3x | 19.6x |
| Fair Price | (51.47) - (40.65) | (49.05) |
| Upside | -5819.3% - -4617.0% | -5549.8% |
| Date | EV/EBITDA |
| 2025-05-23 | 0.43 |
| 2025-05-22 | 0.44 |
| 2025-05-21 | 0.46 |
| 2025-05-20 | 0.44 |
| 2025-05-19 | 0.44 |
| 2025-05-16 | 0.43 |
| 2025-05-15 | 0.44 |
| 2025-05-14 | 0.49 |
| 2025-05-13 | 0.46 |
| 2025-05-12 | 0.45 |
| 2025-05-09 | 0.45 |
| 2025-05-08 | 0.42 |
| 2025-05-07 | 0.41 |
| 2025-05-06 | 0.42 |
| 2025-05-05 | 0.39 |
| 2025-05-02 | 0.37 |
| 2025-05-01 | 0.38 |
| 2025-04-30 | 0.39 |
| 2025-04-29 | 0.44 |
| 2025-04-28 | 0.44 |
| 2025-04-25 | 0.44 |
| 2025-04-24 | 0.31 |
| 2025-04-23 | 0.44 |
| 2025-04-22 | 0.49 |
| 2025-04-21 | 0.55 |
| 2025-04-17 | 0.56 |
| 2025-04-16 | 0.55 |
| 2025-04-15 | 0.54 |
| 2025-04-14 | 0.53 |
| 2025-04-11 | 0.53 |
| 2025-04-10 | 0.54 |
| 2025-04-09 | 0.52 |
| 2025-04-08 | 0.52 |
| 2025-04-07 | 0.49 |
| 2025-04-04 | 0.55 |
| 2025-04-03 | 0.53 |
| 2025-04-02 | 0.52 |
| 2025-04-01 | 0.53 |
| 2025-03-31 | 0.52 |
| 2025-03-28 | 0.49 |
| 2025-03-27 | 0.49 |
| 2025-03-26 | 0.48 |
| 2025-03-25 | 0.48 |
| 2025-03-24 | 0.48 |
| 2025-03-21 | 0.48 |
| 2025-03-20 | 0.47 |
| 2025-03-19 | 0.46 |
| 2025-03-18 | 0.44 |
| 2025-03-17 | 0.43 |
| 2025-03-14 | 0.46 |